NCT00986570View on ClinicalTrials.gov

Clinical Trial to Assess Efficacy, Safety and Tolerability of Botulinum Toxin A (Xeomin®) in Treatment of Expression Wrinkles in the Upper Third of the Face

PHASE3CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

November 30, 2010

Conditions
Skin Aging
Interventions
BIOLOGICAL

Botulinum Toxin A

100 U DL50 lyophilized powder for reconstitution in 1 ml Saline Solution 0.9%.

Trial Locations (1)

04022-000

Universidade Federal de São Paulo/Hospital São Paulo, São Paulo

Sponsors
All Listed Sponsors
lead

Biolab Sanus Farmaceutica

INDUSTRY